DK1446404T3 - Rosiglitazonedisylater og deres anvendelse som antidiabetika - Google Patents

Rosiglitazonedisylater og deres anvendelse som antidiabetika

Info

Publication number: DK1446404T3
Authority: DK; Denmark
Prior art keywords: disylates; antidiabetics; rosiglitazone; salt; ethanedisulfonicacid
Prior art date: 2001-11-21

Application number

DK02779713T

Other languages

English (en)

Inventor

Tim Chien Ting Ho

Michael John Millan

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-21

Filing date

2002-11-21

Publication date

2006-10-09

2001-11-21 Priority claimed from GB0127931A external-priority patent/GB0127931D0/en

2001-11-21 Priority claimed from GB0127933A external-priority patent/GB0127933D0/en

2001-11-21 Priority claimed from GB0127932A external-priority patent/GB0127932D0/en

2002-11-21 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2006-10-09 Application granted granted Critical

2006-10-09 Publication of DK1446404T3 publication Critical patent/DK1446404T3/da

Links

YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 title abstract 3
230000003178 anti-diabetic effect Effects 0.000 title 1
229960004586 rosiglitazone Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 1
AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK02779713T 2001-11-21 2002-11-21 Rosiglitazonedisylater og deres anvendelse som antidiabetika DK1446404T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0127931A GB0127931D0 (en)	2001-11-21	2001-11-21	Novel compounds
GB0127933A GB0127933D0 (en)	2001-11-21	2001-11-21	Novel compounds
GB0127932A GB0127932D0 (en)	2001-11-21	2001-11-21	Novel compounds

Publications (1)

Publication Number	Publication Date
DK1446404T3 true DK1446404T3 (da)	2006-10-09

Family

ID=27256332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02779713T DK1446404T3 (da)	2001-11-21	2002-11-21	Rosiglitazonedisylater og deres anvendelse som antidiabetika

Country Status (12)

Country	Link
US (1)	US20050107440A1 (da)
EP (1)	EP1446404B1 (da)
JP (1)	JP2005515987A (da)
KR (1)	KR20040062965A (da)
CN (1)	CN1612874A (da)
AT (1)	ATE329914T1 (da)
AU (1)	AU2002343052A1 (da)
DE (1)	DE60212434T2 (da)
DK (1)	DK1446404T3 (da)
ES (1)	ES2266593T3 (da)
PT (1)	PT1446404E (da)
WO (1)	WO2003045947A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005023803A1 (en) *	2003-09-10	2005-03-17	Biocon Limited	Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione
DE102005034406A1 (de) *	2005-07-22	2007-02-01	Ratiopharm Gmbh	Neue Salze von Rosiglitazon
ATE481094T1 (de)	2005-12-22	2010-10-15	Kiacta Sarl	Behandlung von diabetischer nephropathie
CA2673022A1 (en) *	2006-12-22	2008-07-03	Bellus Health (International) Limited	Methods, compounds, and compositions for treating metabolic disorders and diabetes
KR20110015254A (ko) *	2009-08-07	2011-02-15	한미홀딩스 주식회사	프라수그렐 디술폰산염 및 이의 결정
CN101758337B (zh)	2009-12-03	2012-02-15	湖南阿斯达生化科技有限公司	一种助焊剂用非卤素活性剂
AT528477A1 (de) *	2024-07-09	2026-01-15	Univ Wien Tech	Mikroträger zur Kultivierung und/oder Expansion von Zellen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7609666L (sv) *	1975-09-12	1977-03-13	Roussel Uclaf	Sett att framstella nya 5-aminometyltiazolderivat
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds

2002
- 2002-11-21 PT PT02779713T patent/PT1446404E/pt unknown
- 2002-11-21 AT AT02779713T patent/ATE329914T1/de not_active IP Right Cessation
- 2002-11-21 CN CNA028267591A patent/CN1612874A/zh active Pending
- 2002-11-21 KR KR10-2004-7007722A patent/KR20040062965A/ko not_active Ceased
- 2002-11-21 JP JP2003547397A patent/JP2005515987A/ja active Pending
- 2002-11-21 AU AU2002343052A patent/AU2002343052A1/en not_active Abandoned
- 2002-11-21 DE DE60212434T patent/DE60212434T2/de not_active Expired - Fee Related
- 2002-11-21 DK DK02779713T patent/DK1446404T3/da active
- 2002-11-21 ES ES02779713T patent/ES2266593T3/es not_active Expired - Lifetime
- 2002-11-21 US US10/496,429 patent/US20050107440A1/en not_active Abandoned
- 2002-11-21 WO PCT/GB2002/005239 patent/WO2003045947A1/en not_active Ceased
- 2002-11-21 EP EP02779713A patent/EP1446404B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2005515987A (ja)	2005-06-02
US20050107440A1 (en)	2005-05-19
EP1446404A1 (en)	2004-08-18
ATE329914T1 (de)	2006-07-15
DE60212434D1 (de)	2006-07-27
CN1612874A (zh)	2005-05-04
ES2266593T3 (es)	2007-03-01
DE60212434T2 (de)	2007-05-24
WO2003045947A1 (en)	2003-06-05
EP1446404B1 (en)	2006-06-14
KR20040062965A (ko)	2004-07-09
PT1446404E (pt)	2006-10-31
AU2002343052A1 (en)	2003-06-10

Similar Documents

Publication	Publication Date	Title
AP1545A (en)	2006-01-12	Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
PT1446404E (pt)	2006-10-31	Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AP1715A (en)	2007-02-28	The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1814A (en)	2008-01-04	Tartrate salts of thiazolidinedione derivative.
DK1349855T3 (da)	2006-12-27	5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
DK1315724T3 (da)	2006-02-20	Thiazolidindionderivat og dets anvendelse som antidiabetikum
AP1785A (en)	2007-10-04	Tartrate salt of thiazolidinedione derivative.
MXPA02012100A (es)	2003-04-25	Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DK1315721T3 (da)	2007-02-19	Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
AP2003002737A0 (en)	2003-03-31	Tartrate salts of thiazolidinedione derivatives
AP2002002684A0 (en)	2002-12-31	5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20075507L (no)	2003-05-27	Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
AP1738A (en)	2007-05-07	Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
BR0112983A (pt)	2003-06-10	Sais tartarato de derivado de tiazolidinodiona
CY1106397T1 (el)	2011-10-12	Βενζολοσουλφονικη 5-(4-(2-(ν-μεθυλο-ν-(2-πυριδιλ)αμινο)αιθοξυ)βενζυλο) θειαζολιδινο-2,4-διονη ˙ διepγασια παρασκευης αυτης ˙ πολυμορφες ι,ιι και ιιι αυτης ˙ και χρηση αυτης ως φαρμακευτικο δραστικο συστατικο
HK1068883A (en)	2005-05-06	5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same